Stay updated on Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision identifiers updated from v3.4.3 to v3.5.0. No visible content or data on the study page appears to be changed.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision history updated to add v3.4.3 and remove v3.4.2.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1, with no substantive changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision updated from v3.4.0 to v3.4.1, a minor technical update that does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedGlossary toggle controls (Show glossary and Hide glossary) were added, and a capitalization change was made to the QC criteria metadata. Revision information now shows v3.4.0 instead of v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check66 days agoChange DetectedRevision history updated: added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.